Press release
Synovial Sarcoma Treatment Market is expected to reach US$ 1646.61 million by 2031 | North America hold 42% share and Major Companies - Pfizer Inc., Dr Reddy's Laboratories, Hetero Healthcare, Teva Pharmaceuticals
Synovial Sarcoma Treatment Market
The Global Synovial Sarcoma Treatment Market size reached US$ 832.47 million in 2023 and is expected to reach US$ 1646.61 million by 2031, growing with a CAGR of 8.9% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "Synovial Sarcoma Treatment Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/synovial-sarcoma-treatment-market?sz
Synovial Sarcoma Treatment Market refers to the global industry focused on therapies used to manage and treat synovial sarcoma, a rare and aggressive soft tissue cancer that commonly affects adolescents and young adults. The market includes chemotherapy, targeted therapy, immunotherapy, radiation therapy, and surgical interventions. Growth is driven by rising cancer incidence, increasing research and clinical trials, advancements in precision medicine, and improved diagnostic techniques, alongside expanding healthcare infrastructure and regulatory support for orphan drug development.
Recent Key Developments of United States:
✅ February 2026: Phase 2 trial data (NCT03951571) confirmed anlotinib's efficacy in reducing recurrence risk post-surgery for high-grade sarcomas.
✅ January 2026: UI Health Care expands TCR therapy access. University of Iowa Health Care began treating patients with T-cell receptor (TCR) therapy for synovial sarcoma, supported by trial data showing tumor shrinkage in 43% of cases and potential for long-term survival.
✅ December 2025: Arizona initiates new immune therapy. A medical center in Arizona pioneered a new immune therapy for synovial sarcoma treatment, expanding access to innovative TCR-based options like those building on TECELRA's success.
✅ November 2025: Adaptimmune advances lete-cel BLA submission. Adaptimmune Therapeutics planned to start a rolling Biologics License Application (BLA) by late 2025 for lete-cel (letetresgene autoleucel) in advanced synovial sarcoma, following positive Phase 2 trial results with 42% response rates.
Recent Key Developments of Japan:
✅ January 2026: Takara Bio starts TBI-1301 confirmatory study. Takara Bio Inc. began a Phase 3 study of TBI-1301 (mipetresgene autoleucel) for NY-ESO-1 expressing synovial sarcoma after cyclophosphamide/fludarabine pre-treatment, aiming for expedited approval under Japan's Sakigake system.
✅ November 2025: Daiichi Sankyo launches DS-2243a trial. Daiichi Sankyo initiated a first-in-human Phase 1 trial (NCT06644755) of DS-2243a for advanced solid tumors including synovial sarcoma, evaluating safety and efficacy in NY-ESO-1 positive patients.
✅ November 2025: PMDA refined approval processes for AI-based therapies, alongside evolving reimbursement for value-based models.
✅ October 2025: AI integration in diagnostics gained traction, with machine learning improving early tumor detection accuracy.
List of the Key Players in the Synovial Sarcoma Treatment Market:
Pfizer Inc.
Dr Reddy's Laboratories
Hetero Healthcare
Teva Pharmaceuticals
Sterling Biotech Ltd.
Baxter International
Janssen Pharmaceuticals
Concord Biotech Ltd.
Novartis AG
Taiho Pharmaceuticals
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/synovial-sarcoma-treatment-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Synovial Sarcoma Treatment Market:
By Treatment: Anti-angiogenesis Drugs, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others.
By End Users: Hospitals, Oncology Centers, Ambulatory Surgical Centers, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=synovial-sarcoma-treatment-market
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Synovial Sarcoma Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Synovial Sarcoma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Synovial Sarcoma Treatment Market in 2026?
◆ What is the projected growth rate of the Synovial Sarcoma Treatment Market through 2034?
◆ Who are the key players in the Synovial Sarcoma Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Synovial Sarcoma Treatment Market is expected to reach US$ 1646.61 million by 2031 | North America hold 42% share and Major Companies - Pfizer Inc., Dr Reddy's Laboratories, Hetero Healthcare, Teva Pharmaceuticals here
News-ID: 4394961 • Views: …
More Releases from DataM Intelligence 4Market Research
VR/AR Technology for Healthcare Market is expected to reach US$ 12.14 billion by …
Market Size and Growth:
The Global VR/AR Technology for Healthcare Market size reached US$ 3.75 billion in 2023 and is expected to reach US$ 12.14 billion by 2031, growing with a CAGR of 15.8% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "VR/AR Technology for Healthcare Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business…
Hemostatic Agents Market is expected to reach US$ 4.15 billion by 2032 | Major C …
Market Size and Growth:
The Global Hemostatic Agents Market size reached US$ 3.01 billion in 2024 and is expected to reach US$ 4.15 billion by 2032, growing at a CAGR of 4.2% during the forecast period 2025-2032.
The Hemostatic Agents Market refers to the global industry focused on products and materials designed to stop bleeding during surgical procedures, trauma, or emergency care. These agents include topical powders, dressings, foams, and gels that…
PARP Inhibitors Market is expected to reach US$ 6.64 billion by 2031 | Major Com …
Market Size and Growth:
The Global PARP Inhibitors Market size reached US$ 3.53 billion in 2023 and is expected to reach US$ 6.64 billion by 2031, growing at a CAGR of 8.3% during the forecast period 2024-2031.
The PARP inhibitors Market refers to the global industry focused on developing, manufacturing, and commercializing drugs that inhibit poly (ADP-ribose) polymerase (PARP) enzymes. These targeted therapies are primarily used in oncology to treat cancers with…
Voice Assistant Market is expected to reach US$ 14.20 billion by 2032 | Major Co …
Market Size and Growth:
The Global Voice Assistant Market size reached US$ 2.73 billion in 2024 and is expected to reach US$ 14.20 billion by 2032, growing with a CAGR of 22.89% during the forecast period 2025-2032.
The Voice Assistant Market refers to the global industry focused on the development, production, and adoption of software and devices that enable users to interact with technology through voice commands. It includes smart speakers, smartphones,…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
